Date: October 5th, 2019

Location: McGill University, Montreal, Canada

Host: Chinese Biopharmaceutical Association-Canada (CBA-Canada)

Theme: The cutting-edge technology, global collaboration for better healthcare and life 

Brief introduction of some speakers: (see Full List)

Dr. Thomas Ming Swi Chang 张明瑞院士

Speech topic 演讲题目: Atificial cells in Biomedicine and Nanobiotherapeutic/人造细胞在生 物医学和纳米生物治疗中的应用

• Father of “Artificial Cells”, Invented the First Artificial Cell 人造细胞之父，发明世上第一个人造细胞

• Fellow, Royal Society of Science of Canada FRSC 加拿大皇家学会院士

• Fellow, Royal College of Physician of Canada FRCPC 加拿大皇家医学院院士

• Director, Artificial Cells & Organs Research Centre, McGill University 麦吉尔大学人造细胞及组织研究中心主任

• Emeritus Professor, Departments of Physiology, Medicine & Biomedical Engineering, Faculty of Medicine, McGill University 麦吉尔大学医学院生理学，生物医药工程学荣誉教授

Dr. Zu-hua Gao 高祖华院士

Speech topic 演讲题目: To be determined 待定

• Fellow, Canadian Academy of Health Sciences FCAHS 加拿大健康科学学术院士

• Fellow, British Royal Society of Medicine 英国皇家医学会院士

• Chair and Chief, Department of Pathology (includes 8 university-affiliated hospitals), Faculty of Medicine, McGill University, 麦吉尔大学医学院及 8 所大学附属医院病理学首席教授

• Pathologist-in-Chief, McGill University Health Center (includes 6 universityaffiliated hospitals) 麦吉尔大学卫生院及 6 所大学附属医院首席病理学医师

Dr. Shou-bai Chao 巢守柏博士

Speech topic 演讲题目: IPO of CanSinoBIO CanSinoBIO 的上市

• Executive Director & Chief Operating Officer, CanSinoBIO 康希诺生物公司执行董事&首席运营师

• 33 Years of Experience in the Biotechnology Industry 拥有 33 年生物技术行业的丰富工作经验

• Formerly served as Vice President & Senior Vice President, AstraZeneca plc 曾担任 AstraZeneca plc 副总裁&高级副总裁

• Formerly served as President & Board Director, Chinese Biopharmaceutical Association-USA 曾担任美国华人生物医药科技协会会长&理事